A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC

Clinical trial NCT06883630 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06883630
Sponsor: RemeGen Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2025-03-13
Primary completion: 2026-08-31
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.